Skin Wellness solutions you can trust for baby’s sensitive skin
Why AVEENO® Baby?
The AVEENO® Baby brand offers a range of baby products for bath and body with skin-soothing ACTIVE NATURALS® Oat and rich emollients to soothe, calm, and protect a range of skin conditions from daily care, dry skin, and sun protection, to more serious skin conditions like eczema.
2.7-aveeno-advert-100-callout.jpg
Share Image:
0
Asset Name:
2.7-aveeno-advert-100-callout_0.jpg
Production Year:
2018
J&J Copy Leader:
Agency Producer Contact Name:
Usages rights coverage (countries/region):
Usage rights terms/length:
Format:
image/jpeg
Size:
140496
Photographer/Illustrators:
Using the benefits of nature to promote healthy skin
AVEENO® ACTIVE NATURALS® ingredients are carefully selected from nature’s botanicals and uniquely formulated through the power of science to deliver visible benefits for baby’s skin.
Colloidal oat
Colloidal oat has long been recommended for a variety of sensitive skin conditions, providing a soothing, comforting effect—making it well suited for use in moisturizers, cleansers, and other products that help cleanse, soothe, and protect the skin.
For more than 60 years, AVEENO® has pioneered innovation unlocking the power of colloidal oat to relieve, restore, and protect sensitive skin.
Proven Triple Oat Formulas soothe and protect itchy, irritated skin due to eczema
Atopic dermatitis affects up to 25% of children, and is most commonly seen first between 3 and 6 months of age.
Moisturizers that soothe, protect, and restore the skin barrier are considered a first-line treatment for atopic dermatitis.
AVEENO® Baby Eczema Therapy Nighttime Balm contains ceramides and non-greasy glycerin to moisturize throughout the night—helping babies and toddlers sleep better and longer.
In fact, there was a 51% Reduction in EASI scores at day 71
AVEENO® Baby Eczema Therapy Moisturizing Cream with Triple Oat Formula, ceramides, and panthenol, relieves dry, itchy, and irritated skin due to eczema & is compatible with Rx therapies.
A clinical study on infants, children and adults with atopic dermatitis has shown:
A reported 72% improvement in Quality of Life scores at 12 weeks
39% reduction in corticoid usage assessed through weight measures at 12 weeks
You must be a US licensed Pediatric MD, DO, NP, or PA to order samples and resources.
Please provide your state license number and licensing state so we can validate your credentials.
This site is intended for US pediatric healthcare professionals. At this time we are unable to validate you as such based on the information you have provided. If you are a US pediatric healthcare professional and believe that your license # should have validated successfully, please contact our Customer Support Team at 1-866-948-6883.
Part of your profile may be incomplete or incorrect. Please check that your name and professional certification information are correct. If you continue to experience issues, please contact our Customer Care Center for Health Care Professionals at 1-866-948-6883.
Part of your profile may be incomplete or incorrect. Please contact our Customer Care Center for Health Care Professionals at 1-866-948-6883.
By registering, you are agreeing to receive information and patient education materials from Johnson & Johnson’s Pediatrics .
Your personal information will be used to fulfill your request for the Johnson & Johnson Pediatrics BundleBox.
Your information will be shared only with Johnson & Johnson Inc., its affiliates, and any third parties working
on their behalf to fulfill your request, and will be governed by our site’s Privacy Policy
Looks like you have an existing account with us. We have made some changes to our site and we need you to create a new password in order to login. Click send to recieve an email with instructions on how to create your new password.
All Fields required, unless otherwise indicated
Will be used as your user name
By submitting your information above, you agree that the information you provide will be governed by our site's Privacy Policy.